37 related articles for article (PubMed ID: 28737980)
1. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
Neelofar K; Arif Z; Ahmad J; Alam K
PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
[TBL] [Abstract][Full Text] [Related]
2. Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins.
Irie Y; Saeki M; Kamisaki Y; Martin E; Murad F
Proc Natl Acad Sci U S A; 2003 May; 100(10):5634-9. PubMed ID: 12719531
[TBL] [Abstract][Full Text] [Related]
3. Exploration of Nitrotyrosine-Containing Proteins and Peptides by Antibody-Based Enrichment Strategies.
Bhat FA; Mangalaparthi KK; Ding H; Jain A; Hsu JS; Peterson JA; Zenka RM; Mun DG; Kandasamy RK; Pandey A
Mol Cell Proteomics; 2024 Mar; 23(3):100733. PubMed ID: 38342410
[TBL] [Abstract][Full Text] [Related]
4. Glycoxidation of mammalian whole histone generates highly immunogenic aggregates: Sera of SLE patients contain autoantibodies against aggregates.
Islam SN; Arif Z; Badar A; Moinuddin ; Khan MA; Alam K
Scand J Immunol; 2024 May; ():e13389. PubMed ID: 38816907
[TBL] [Abstract][Full Text] [Related]
5. Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis.
Choi SE; Park DJ; Kang JH; Lee SS
Ann Med; 2023 Dec; 55(1):1009-1017. PubMed ID: 36896834
[TBL] [Abstract][Full Text] [Related]
6. Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins.
Van Fossen EM; Grutzius S; Ruby CE; Mourich DV; Cebra C; Bracha S; Karplus PA; Cooley RB; Mehl RA
Front Chem; 2022; 10():835229. PubMed ID: 35265586
[TBL] [Abstract][Full Text] [Related]
7. Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer.
Salvatori L; Spallotta F; Gaetano C; Illi B
Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947954
[TBL] [Abstract][Full Text] [Related]
8. A chemical field guide to histone nonenzymatic modifications.
Faulkner S; Maksimovic I; David Y
Curr Opin Chem Biol; 2021 Aug; 63():180-187. PubMed ID: 34157651
[TBL] [Abstract][Full Text] [Related]
9. Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus.
Ahmad R; Ahsan H
Clin Exp Med; 2014 Feb; 14(1):1-11. PubMed ID: 23179301
[TBL] [Abstract][Full Text] [Related]
10. Nitration of H2B histone elicits an immune response in experimental animals.
Khan MA; Alam K; Hassan SM; Rizvi MMA
Autoimmunity; 2017 Jun; 50(4):232-240. PubMed ID: 28737980
[TBL] [Abstract][Full Text] [Related]
11. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus.
Khan MA; Dixit K; Moinuddin ; Arif Z; Alam K
Biochimie; 2014 Feb; 97():104-13. PubMed ID: 24113317
[TBL] [Abstract][Full Text] [Related]
12. Peroxynitrite-induced modification of H2A histone presents epitopes which are strongly bound by human anti-DNA autoantibodies: role of peroxynitrite-modified-H2A in SLE induction and progression.
Dixit K; Khan MA; Sharma YD; Moinuddin ; Alam K
Hum Immunol; 2011 Mar; 72(3):219-25. PubMed ID: 21182886
[TBL] [Abstract][Full Text] [Related]
13. Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis.
Khan MA; Dixit K; Uddin M; Malik A; Alam K
Scand J Rheumatol; 2012; 41(6):426-33. PubMed ID: 22985259
[TBL] [Abstract][Full Text] [Related]
14. Peroxynitrite-modified histone as a pathophysiological biomarker in autoimmune diseases.
Khan MA; Alam K; Zafaryab M; Rizvi MMA
Biochimie; 2017 Sep; 140():1-9. PubMed ID: 28619676
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
